awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47591552-45FDA306-4975-4986-B623-8878D430206F
Q47591552-45FDA306-4975-4986-B623-8878D430206F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47591552-45FDA306-4975-4986-B623-8878D430206F
Antibody Therapeutics Targeting Aβ and Tau.
P2860
Q47591552-45FDA306-4975-4986-B623-8878D430206F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47591552-45FDA306-4975-4986-B623-8878D430206F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
61823cdaa326f8ded45f0d766e572e8e408b133a
P2860
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.